239 related articles for article (PubMed ID: 22582077)
61. Probiotics
Wang T; Zheng N; Luo Q; Jiang L; He B; Yuan X; Shen L
Front Immunol; 2019; 10():1235. PubMed ID: 31214189
[TBL] [Abstract][Full Text] [Related]
62. Enhanced viability of Lactobacillus reuteri for probiotics production in mixed solid-state fermentation in the presence of Bacillus subtilis.
Zhang YR; Xiong HR; Guo XH
Folia Microbiol (Praha); 2014 Jan; 59(1):31-6. PubMed ID: 23775321
[TBL] [Abstract][Full Text] [Related]
63. Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 to reduce Group B Streptococcus colonization in pregnant women: A randomized controlled trial.
Ho M; Chang YY; Chang WC; Lin HC; Wang MH; Lin WC; Chiu TH
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):515-8. PubMed ID: 27590374
[TBL] [Abstract][Full Text] [Related]
64. Biofilms of vaginal Lactobacillus reuteri CRL 1324 and Lactobacillus rhamnosus CRL 1332: kinetics of formation and matrix characterization.
Leccese Terraf MC; Juárez Tomás MS; Rault L; Le Loir Y; Even S; Nader-Macías ME
Arch Microbiol; 2016 Sep; 198(7):689-700. PubMed ID: 27146055
[TBL] [Abstract][Full Text] [Related]
65. Next-Generation Probiotic Therapy to Protect the Intestines From Injury.
Ragan MV; Wala SJ; Goodman SD; Bailey MT; Besner GE
Front Cell Infect Microbiol; 2022; 12():863949. PubMed ID: 35837474
[TBL] [Abstract][Full Text] [Related]
66. Clinical and microbiological evaluation of the effect of Lactobacillus reuteri in the treatment of mucositis and peri-implantitis: A triple-blind randomized clinical trial.
Galofré M; Palao D; Vicario M; Nart J; Violant D
J Periodontal Res; 2018 Jun; 53(3):378-390. PubMed ID: 29352461
[TBL] [Abstract][Full Text] [Related]
67. Lactic acid bacteria protect human intestinal epithelial cells from Staphylococcus aureus and Pseudomonas aeruginosa infections.
Affhan S; Dachang W; Xin Y; Shang D
Genet Mol Res; 2015 Dec; 14(4):17044-58. PubMed ID: 26681052
[TBL] [Abstract][Full Text] [Related]
68. Multiple Proteins of
El-Chami C; Choudhury R; Mohammedsaeed W; McBain AJ; Kainulainen V; Lebeer S; Satokari R; O'Neill CA
Front Microbiol; 2022; 13():875542. PubMed ID: 35633665
[TBL] [Abstract][Full Text] [Related]
69. Glycerol supplementation enhances L. reuteri's protective effect against S. Typhimurium colonization in a 3-D model of colonic epithelium.
De Weirdt R; Crabbé A; Roos S; Vollenweider S; Lacroix C; van Pijkeren JP; Britton RA; Sarker S; Van de Wiele T; Nickerson CA
PLoS One; 2012; 7(5):e37116. PubMed ID: 22693569
[TBL] [Abstract][Full Text] [Related]
70. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.
Martinez RC; Seney SL; Summers KL; Nomizo A; De Martinis EC; Reid G
Microbiol Immunol; 2009 Sep; 53(9):487-95. PubMed ID: 19703242
[TBL] [Abstract][Full Text] [Related]
71. The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3.
Kisich KO; Howell MD; Boguniewicz M; Heizer HR; Watson NU; Leung DY
J Invest Dermatol; 2007 Oct; 127(10):2368-80. PubMed ID: 17460726
[TBL] [Abstract][Full Text] [Related]
72. Exploring the wound healing, anti-inflammatory, anti-pathogenic and proteomic effects of lactic acid bacteria on keratinocytes.
Brandi J; Cheri S; Manfredi M; Di Carlo C; Vita Vanella V; Federici F; Bombiero E; Bazaj A; Rizzi E; Manna L; Cornaglia G; Marini U; Valenti MT; Marengo E; Cecconi D
Sci Rep; 2020 Jul; 10(1):11572. PubMed ID: 32665600
[TBL] [Abstract][Full Text] [Related]
73. In vitro modulation of probiotic bacteria on the biofilm of Candida glabrata.
Chew SY; Cheah YK; Seow HF; Sandai D; Than LT
Anaerobe; 2015 Aug; 34():132-8. PubMed ID: 26028405
[TBL] [Abstract][Full Text] [Related]
74. A topical treatment containing heat-treated Lactobacillus johnsonii NCC 533 reduces Staphylococcus aureus adhesion and induces antimicrobial peptide expression in an in vitro reconstructed human epidermis model.
Rosignoli C; Thibaut de Ménonville S; Orfila D; Béal M; Bertino B; Aubert J; Mercenier A; Piwnica D
Exp Dermatol; 2018 Apr; 27(4):358-365. PubMed ID: 29380443
[TBL] [Abstract][Full Text] [Related]
75. Lactobacillus reuteri ATCC 55730 and L22 display probiotic potential in vitro and protect against Salmonella-induced pullorum disease in a chick model of infection.
Zhang D; Li R; Li J
Res Vet Sci; 2012 Aug; 93(1):366-73. PubMed ID: 21764090
[TBL] [Abstract][Full Text] [Related]
76. Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes.
Ventress JK; Partridge LJ; Read RC; Cozens D; MacNeil S; Monk PN
PLoS One; 2016; 11(7):e0160387. PubMed ID: 27467693
[TBL] [Abstract][Full Text] [Related]
77. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling.
Thomas CM; Hong T; van Pijkeren JP; Hemarajata P; Trinh DV; Hu W; Britton RA; Kalkum M; Versalovic J
PLoS One; 2012; 7(2):e31951. PubMed ID: 22384111
[TBL] [Abstract][Full Text] [Related]
78. Sacha Inchi Oil (Plukenetia volubilis L.), effect on adherence of Staphylococus aureus to human skin explant and keratinocytes in vitro.
Gonzalez-Aspajo G; Belkhelfa H; Haddioui-Hbabi L; Bourdy G; Deharo E
J Ethnopharmacol; 2015 Aug; 171():330-4. PubMed ID: 26087228
[TBL] [Abstract][Full Text] [Related]
79. A novel method for screening of potential probiotics for high adhesion capability.
Wang X; Wu Q; Deng K; Wei Q; Hu P; He J; Liu H; Zheng Y; Wei H; Shah NP; Chen T
J Dairy Sci; 2015 Jul; 98(7):4310-7. PubMed ID: 25912863
[TBL] [Abstract][Full Text] [Related]
80. Potential probiotic characterization of Lactobacillus reuteri from traditional Chinese highland barley wine and application for room-temperature-storage drinkable yogurt.
Chen S; Chen L; Chen L; Ren X; Ge H; Li B; Ma G; Ke X; Zhu J; Li L; Feng Y; Li Y
J Dairy Sci; 2018 Jul; 101(7):5780-5788. PubMed ID: 29705426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
